Institute Pasteur Korea and Euroscreen Ink GPCR Drug-Discovery Deal

Feb 27, 2006

NEW YORK, Feb. 27 (GenomeWeb News) - The Institute Pasteur Korea and Euroscreen will collaborate in GPCR screening, the partners announced today.

Under the deal, Euroscreen will provide receptor cell lines and GPCR library compounds for analysis on IPK's high-throughput screening platform.

Additional details were not provided.

Breaking News

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.